Effects of SativexⓇ on cognitive function in patients with multiple sclerosis: A systematic review and meta-analysis
出版年份 2022 全文链接
标题
Effects of SativexⓇ on cognitive function in patients with multiple sclerosis: A systematic review and meta-analysis
作者
关键词
-
出版物
Multiple Sclerosis and Related Disorders
Volume 68, Issue -, Pages 104173
出版商
Elsevier BV
发表日期
2022-09-15
DOI
10.1016/j.msard.2022.104173
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Comparison of the Effectiveness and Tolerability of Nabiximols (THC:CBD) Oromucosal Spray versus Oral Dronabinol (THC) as Add-on Treatment for Severe Neuropathic Pain in Real-World Clinical Practice: Retrospective Analysis of the German Pain e-Registry
- (2022) Michael A Ueberall et al. Journal of Pain Research
- Klinische Umsetzbarkeit der kognitiven Screeningbatterie BICAMS bei Patienten mit Multipler Sklerose: Ergebnisse der Machbarkeitsstudie in Deutschland
- (2021) Iris-Katharina Penner et al. NERVENARZT
- Safety and tolerability of nabiximols oromucosal spray: a review of more than 15 years” accumulated evidence from clinical trials
- (2021) José María Prieto González et al. Expert Review of Neurotherapeutics
- Cortical Thickness and Serum NfL Explain Cognitive Dysfunction in Newly Diagnosed Patients With Multiple Sclerosis
- (2021) Álvaro J. Cruz-Gomez et al. Neurology-Neuroimmunology & Neuroinflammation
- Predictors of Nabiximols (Sativex®) discontinuation over long-term follow-up: a real-life study
- (2020) Antonio Carotenuto et al. JOURNAL OF NEUROLOGY
- Disease-modifying treatments and cognition in relapsing-remitting multiple sclerosis
- (2020) Nils C. Landmeyer et al. NEUROLOGY
- Long-term assessment of the cognitive effects of nabiximols in patients with multiple sclerosis: A pilot study
- (2020) Giulia Alessandria et al. CLINICAL NEUROLOGY AND NEUROSURGERY
- Cognitive impairment in multiple sclerosis: clinical management, MRI, and therapeutic avenues
- (2020) Ralph H B Benedict et al. LANCET NEUROLOGY
- Cognitive Dysfunctions and Assessments in Multiple Sclerosis
- (2019) Celia Oreja-Guevara et al. Frontiers in Neurology
- Predictors of vocational status among persons with multiple sclerosis
- (2019) Christopher A. Povolo et al. Multiple Sclerosis and Related Disorders
- The Pharmacokinetics and the Pharmacodynamics of Cannabinoids
- (2018) C.J. Lucas et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- The therapeutic effects of Cannabis and cannabinoids: An update from the National Academies of Sciences, Engineering and Medicine report
- (2018) Donald I. Abrams European Journal of Internal Medicine
- Sativex® as Add-on therapy Vs. further optimized first-line ANTispastics (SAVANT) in resistant multiple sclerosis spasticity: a double-blind, placebo-controlled randomised clinical trial
- (2018) Jolana Markovà et al. INTERNATIONAL JOURNAL OF NEUROSCIENCE
- Balance worsening associated with nabiximols in multiple sclerosis
- (2018) Letizia Castelli et al. Multiple Sclerosis Journal
- Balance worsening associated with nabiximols in multiple sclerosis
- (2018) Letizia Castelli et al. Multiple Sclerosis Journal
- Cannabinoids and Pain: New Insights From Old Molecules
- (2018) Sonja Vučković et al. Frontiers in Pharmacology
- The burden of multiple sclerosis 2015: Methods of data collection, assessment and analysis of costs, quality of life and symptoms
- (2017) Gisela Kobelt et al. Multiple Sclerosis Journal
- The burden of multiple sclerosis 2015: Methods of data collection, assessment and analysis of costs, quality of life and symptoms
- (2017) Gisela Kobelt et al. Multiple Sclerosis Journal
- Cognitive impairment predicts disability progression and cortical thinning in MS: An 8-year study
- (2016) Marco Pitteri et al. Multiple Sclerosis Journal
- Cognitive impairment among patients with multiple sclerosis: associations with employment and quality of life
- (2016) J Campbell et al. POSTGRADUATE MEDICAL JOURNAL
- Cognitive impairment predicts disability progression and cortical thinning in MS: An 8-year study
- (2016) Marco Pitteri et al. Multiple Sclerosis Journal
- Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor
- (2015) R B Laprairie et al. BRITISH JOURNAL OF PHARMACOLOGY
- Sativex® and clinical–neurophysiological measures of spasticity in progressive multiple sclerosis
- (2015) Letizia Leocani et al. JOURNAL OF NEUROLOGY
- Clinical and imaging assessment of cognitive dysfunction in multiple sclerosis
- (2015) Maria A Rocca et al. LANCET NEUROLOGY
- Drug-resistant MS spasticity treatment with Sativex®add-on and driving ability
- (2014) M. Freidel et al. ACTA NEUROLOGICA SCANDINAVICA
- Dare to Delay? The Impacts of Adolescent Alcohol and Marijuana Use Onset on Cognition, Brain Structure, and Function
- (2013) Krista M. Lisdahl et al. Frontiers in Psychiatry
- Performance of young adult cannabis users on neurocognitive measures of impulsive behavior and their relationship to symptoms of cannabis use disorders
- (2012) Raul Gonzalez et al. JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY
- A double-blind, randomized, placebo-controlled, parallel-group study of THC/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis
- (2012) R. M. Langford et al. JOURNAL OF NEUROLOGY
- Symptomatic therapy in multiple sclerosis: the role of cannabinoids in treating spasticity
- (2012) Verena Isabell Leussink et al. Therapeutic Advances in Neurological Disorders
- Neuropsychological deficits associated with cannabis use in young adults
- (2011) Jon E. Grant et al. DRUG AND ALCOHOL DEPENDENCE
- A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex®), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis
- (2011) A. Novotna et al. EUROPEAN JOURNAL OF NEUROLOGY
- A placebo-controlled, parallel-group, randomized withdrawal study of subjects with symptoms of spasticity due to multiple sclerosis who are receiving long-term Sativex® (nabiximols)
- (2011) W Notcutt et al. Multiple Sclerosis Journal
- Recommendations for a Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS)
- (2011) DW Langdon et al. Multiple Sclerosis Journal
- Effects of endocannabinoid system modulation on cognitive and emotional behavior
- (2011) Claudio Zanettini Frontiers in Behavioral Neuroscience
- Longitudinal study of cognition among adolescent marijuana users over three weeks of abstinence
- (2010) Karen L. Hanson et al. ADDICTIVE BEHAVIORS
- Functional MRI evidence for inefficient attentional control in adolescent chronic cannabis abuse
- (2010) Yalchin Abdullaev et al. BEHAVIOURAL BRAIN RESEARCH
- Randomized controlled trial of Sativex to treat detrusor overactivity in multiple sclerosis
- (2010) RBC Kavia et al. Multiple Sclerosis Journal
- A double-blind, randomized, placebo-controlled, parallel-group study of Sativex, in subjects with symptoms of spasticity due to multiple sclerosis
- (2010) C. Collin et al. NEUROLOGICAL RESEARCH
- The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
- (2009) Alessandro Liberati et al. PLOS MEDICINE
- Psychopathological and Cognitive Effects of Therapeutic Cannabinoids in Multiple Sclerosis
- (2008) Massimiliano Aragona et al. CLINICAL NEUROPHARMACOLOGY
- Cognitive impairment in multiple sclerosis
- (2008) Nancy D Chiaravalloti et al. LANCET NEUROLOGY
- The diverse CB1and CB2receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin
- (2007) R G Pertwee BRITISH JOURNAL OF PHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now